One study found that mice lacking CD137L had reduced microglial activation compared to wild-type (WT) controls in a murine model of multiple sclerosis, suggesting CD137L could have an important role in modulating CNS trauma or disease (Yeo et al., 2012). This evidence concerns the gene TNFSF9 and multiple sclerosis.